The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
DatapointsFull Access

Health Conditions Associated With Severe Illness From COVID-19 Among Individuals With Serious Mental Illness

Published Online:https://doi.org/10.1176/appi.ps.202000300

Individuals with serious mental illness have more chronic medical conditions that increase their risk for contracting severe COVID-19 compared with individuals without serious mental illness and are more likely to be distinctly affected by the pandemic. For example, individuals with serious mental illness may face increased difficulties taking time off work and may experience health system–level barriers to testing and treatment (1). Furthermore, social isolation due to physical distancing requirements may exacerbate their mental illness (2).

A recent study has reported that comorbid health conditions such as obesity, hypertension, and diabetes are highly prevalent among patients hospitalized with COVID-19 (3). According to guidance from the Centers for Disease Control and Prevention (CDC) as of October 2020 (4), people with asthma, obesity, hypertension, bronchitis, heart conditions, diabetes, kidney disease, liver disease, and compromised immune systems (i.e., current smokers or individuals undergoing cancer treatment) are or might be at an increased risk for severe illness from COVID-19 compared with individuals without these conditions.

Using survey-weighted data from the 2015–2018 National Survey on Drug Use and Health, a nationally representative sample of noninstitutionalized nonhomeless respondents (N=226,600), we found that individuals with serious mental illness (N=9,700, weighted N=10.8 million) have higher prevalence of most of the health conditions associated with severe COVID-19 compared with individuals without serious mental illness (N=216,900, weighted N=260 million) (Figure 1). Specifically, among individuals with serious mental illness, the rate of asthma was 19% (N=1,843); of bronchitis, 11% (N=1,067); of nicotine dependence, 21% (N=2,037); and of obesity, 46% (N=4,462). Statistical significance was designated a priori at p≤0.05; all differences in the rates of medical conditions were statistically significant in the nonstratified sample (see online supplement). To address the greater risk for more severe COVID-19 among people age 65 or older, we stratified the estimates by age and found higher rates of all the CDC-identified conditions, except for cancer, among those ages ≥65 and having serious mental illness than among those ages ≥65 without serious mental illness.

FIGURE 1.

FIGURE 1. Underlying medical conditions of individuals with and without serious mental illnessa

aThe Ns for the percentages shown here are in Appendix Table 1 of the online supplement.

Our findings suggest that significant health conditions are prevalent among individuals with serious mental illness, which may increase their risk for experiencing severe COVID-19. As states have declared emergencies because of COVID-19, many routine services previously available to patients with serious mental illness have been limited, refocused, or closed (5). Ongoing efforts appear to be warranted to ensure that services remain available to individuals with serious mental illness during this pandemic.

Department of Health Policy and Management, University of Maryland, College Park (Novak, Ali, Chen); Department of Health Professions, Hofstra University, Hempstead, New York (Sanmartin). Tami L. Mark, Ph.D., and Alexander J. Cowell, Ph.D., are editors of this column.
Send correspondence to Dr. Novak ().

The authors report no financial relationships with commercial interests.

References

1 Druss BG: Addressing the COVID-19 pandemic in populations with serious mental illness. JAMA Psychiatry 2020. doi: 10.1001/jamapsychiatry.2020.0894Crossref, MedlineGoogle Scholar

2 Xiang YT, Jin Y, Cheung T: Joint international collaboration to combat mental health challenges during the coronavirus disease 2019 pandemic. JAMA Psychiatry 2020. doi: 10.1001/jamapsychiatry.2020.1057CrossrefGoogle Scholar

3 Richardson S, Hirsch JS, Narasimhan M, et al.: Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area. JAMA 2020. doi: 10.1001/jama.2020.6775CrossrefGoogle Scholar

4 People with Certain Medical Conditions. Atlanta, Centers for Disease Control and Prevention, 2020. https://www.cdc.gov/coronavirus/2019-ncov/need-extra-precautions/groups-at-higher-risk.html. Accessed Oct 21, 2020Google Scholar

5 Li L: Challenges and priorities in responding to COVID-19 in inpatient psychiatry. Psychiatr Serv 2020; 71:624–626LinkGoogle Scholar